Are viral or host factors predictive of response to interferon–ribavirin in transplant patients with hepatitis C?
✍ Scribed by Bruno Roche; Didier Samuel
- Book ID
- 116652110
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 225 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Recurrent hepatitis C infection is an important cause of progressive fibrosis, cirrhosis, and graft loss following orthotopic liver transplantation. Treatment for posttransplant recurrence of hepatitis C with interferon-based therapy is difficult but results in loss of detectable virus in up to 30%
We read with great interest the article published in a recent issue of HEPATOLOGY. 1 Shirakawa et al. enrolled 120 patients with chronic hepatitis C (CHC) infected with genotype 1 hepatitis C virus (HCV-1) and high baseline viral loads (HVL), defined by HCV RNA levels Ն 10 5 international units (IU)